Drug-Drug Compatibility Studies:
- Determine Suitable Dosage Strengths Early: Study combinations at varying ratios (e.g., 10:90 to 90:10) to identify the most suitable dosage strengths early in development.
- Rational Design of Fixed Dose Combinations (FDCs): FormSCI enables the rational design of FDCs, optimizing the combination of two or more APIs in a single dosage form. The platform tests combinations to find the best possible formulation for efficacy, safety, and patient compliance.
- Flexible Ratio Studies: Whether you need to study a combination at 10:90 or 90:10 or any ratio in between, FormSCI provides the flexibility in formulation design. This allows you to test a wide range of combinations and identify the most stable and effective options.
- Early Formulation Development: By ensuring compatibility and stability of combination products early in formulation development, FormSCI accelerates the development process.